Valiant Co

Valiant Co Operating Expenses

The Total Operating Expenses of Valiant Co (002643.SZ) as of Nov 19, 2026 is 561.16 M CNY. In the previous year, Total Operating Expenses was 776.96 M CNY — a change of -27.78% (lower).

Operating Expenses

561.16 MCNY

YoY

-27.78%

Last updated:

Total Operating Expenses of Valiant Co is 2025 561.16 M CNY. Total Operating Expenses of Valiant Co was 2024 776.96 M CNY. It decreases by -27.78% lower compared to the previous year.

The Valiant Co Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
395.24 M CNY
Jan 1, 2019
473.34 M CNY
Jan 1, 2020
466.03 M CNY
Jan 1, 2021
585.68 M CNY
Jan 1, 2022
750.05 M CNY
Jan 1, 2023
718.88 M CNY
Jan 1, 2024
776.96 M CNY
Jan 1, 2025
561.16 M CNY
The Valiant Co Operating Expenses history
YEAROperating ExpensesYoY
561.16 MCNY-27.78%
776.96 MCNY+8.08%
718.88 MCNY-4.16%
750.05 MCNY+28.07%
585.68 MCNY+25.67%
466.03 MCNY-1.55%
473.34 MCNY+19.76%
395.24 MCNY+9.65%
360.47 MCNY+6.67%
337.94 MCNY-10.65%
378.22 MCNY+52.61%
247.83 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Co Stock analysis

What does Valiant Co do? Valiant Co., Ltd. generates revenue through three core business segments. The Information Materials Industry segment produces and sells display materials and functional materials, targeting customers in the electronics and manufacturing sectors. The Environmental Protection Materials Industry segment develops and manufactures new zeolite environmental protection materials for tail gas purification, serving automotive and industrial clients requiring emission control solutions. The Large Health Industry segment focuses on pharmaceutical production, life sciences, and in vitro diagnostic services, catering to healthcare providers and medical facilities. The company's products include display materials, functional materials, new zeolite environmental protection materials, pharmaceuticals, and in vitro diagnostic services. These offerings are sold across the three industry segments, with the Environmental Protection Materials segment specifically addressing tail gas purification needs. The Large Health Industry segment's in vitro diagnostic services support healthcare operations through specialized medical solutions. Valiant Co., Ltd. serves diverse customer segments including electronics manufacturers, automotive industries, industrial emission control clients, and healthcare providers. The firm's revenue streams are derived from the sale of physical products like display materials and zeolite materials, as well as service-based offerings in diagnostics and pharmaceuticals. The company's business model relies on manufacturing and selling these products across its three operational segments. Valiant Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Co stock

Total Operating Expenses of Valiant Co is 561.16 M CNY in 2025.

Total Operating Expenses of Valiant Co changed from 776.96 M CNY to 561.16 M CNY, representing a -27.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Valiant Co since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Valiant Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Valiant Co

All Key Metrics — Valiant Co